Helping others in real life and in the laboratory: pride and prosocial behavior.

Background: Prosocial behavior may depend on the emotions experienced, and positive emotions such as pride may promote helping, offering support, donating, and other prosocial activities. Two studies were conducted to examine the relationship between pride and prosocial behavior.

Participants And Procedure: A correlational study, Study 1 ( = 365), was conducted during the second week of the 2022 war in Ukraine.

Established focal therapy-HIFU, IRE, or cryotherapy-where are we now?-a systematic review and meta-analysis.

Introduction: Focal Therapy (FT) is a treatment option for the treatment of limited volume clinically significant prostate cancer (csPCa). We aim to systematically review outcomes of established FT modalities to assess the contemporary baseline and identify gaps in evidence that will aid in further trial and study design.

Methods: We conducted a systematic review and meta-analysis of all primary studies reporting outcomes of FT using cryotherapy, high-intensity focused ultrasound (HIFU), and irreversible electroporation (IRE).

Comparative analysis of electrophoresis and interferometric optical detection method for molecular weight determination of proteins.

Analytical detection methods play a pivotal role in scientific research, enabling the identification and quantification of specific analytes in various disciplines. This scientific report aims to compare two very different methodologies for determining the Molecular Mass (MM, also known as Molecular Weight, MW) of proteins: electrophoresis gel and the Interferometric Optical Detection Method (IODM). For this purpose, several proteins with different MM were selected.

Salvage treatments after focal therapy for prostate cancer - a comprehensive review.

Objective: To review the literature on salvage treatments after focal therapy (FT) for prostate cancer (PCa).

Materials And Methods: A non-systematic literature review was conducted on PubMed, Scopus, and Web of Science up to March 15, 2024, for studies that assessed salvage treatment outcomes in patients with recurrent PCa after primary FT. Original prospective and retrospective studies with more than 10 patients were included.